Page last updated: 2024-08-25

9-aminocamptothecin and Stomach Neoplasms

9-aminocamptothecin has been researched along with Stomach Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Avadhani, A; Karrison, T; Kindler, HL; Mani, S; Vokes, EE; Wade-Oliver, K	1

Trials

1 trial(s) available for 9-aminocamptothecin and Stomach Neoplasms

Article	Year
9-Aminocamptothecin (9-AC) given as a 120-hour continuous infusion in patients with advanced adenocarcinomas of the stomach and gastroesophageal junction: A phase II trial of the University of Chicago phase II consortium. Investigational new drugs, 2004, Volume: 22, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Camptothecin; Esophageal Neoplasms; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Stomach Neoplasms; Survival Rate; Treatment Outcome	2004

Article

Year

9-Aminocamptothecin (9-AC) given as a 120-hour continuous infusion in patients with advanced adenocarcinomas of the stomach and gastroesophageal junction: A phase II trial of the University of Chicago phase II consortium.

Investigational new drugs, 2004, Volume: 22, Issue:3

Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Camptothecin; Esophageal Neoplasms; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Stomach Neoplasms; Survival Rate; Treatment Outcome

2004